Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders

Details for Australian Patent Application No. 2007325387 (hide)

Owner KAI Pharmaceuticals, Inc.

Inventors Walter, Sarah; Bell, Gregory; Karim, Felix

Agent Griffith Hack

Pub. Number AU-A-2007325387

PCT Pub. Number WO2008/067199

Priority 60/859,597 16.11.06 US

Filing date 16 November 2007

Wipo publication date 5 June 2008

International Classifications

A01N 37/18 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing the group CON, e.g. carboxylic acid amides or imides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/067199 Priority application(s): WO2008/067199

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007325393-Food and beverage emulsifiers

2007325365-Methods for the treatment of alcohol abuse, addiction and dependency